Quilter Plc’s AstraZeneca AZN Stock Holding History

Quilter Plc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,797	Closed	-$614K	–	151
2021 Q3	$614K	Buy	3,797 +101	+3%	+$11.8K	0.02%	163
2021 Q2	$612K	Sell	3,696 -5,887	-61%	-$646K	0.02%	163
2021 Q1	$1.31M	Sell	9,583 -9	-0.1%	-$905	0.04%	134
2020 Q4	$1.31M	Buy	9,592 +4,763	+99%	+$504K	0.05%	109
2020 Q3	$684K	Buy	+4,829	New	+$537K	0.03%	129

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Quilter Plc's AZN Position: Q4 2021 in Review

Quilter Plc sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 3,797 shares — an estimated $614K sold.

Quilter Plc first reported a position in AZN in Q3 2020 and held it in 5 quarters. The position peaked at $1.31M in Q1 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Quilter Plc reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Quilter Plc sold 3,797 AstraZeneca shares in Q4 2021, an estimated $614K.
Quilter Plc first reported a position in AstraZeneca in Q3 2020 and held it in 5 quarters.
Quilter Plc's AstraZeneca position peaked at $1.31M in Q1 2021.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Quilter Plc's 13F filing for Q4 2021, filed 14 Feb 2022.